Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial.
Rosenson, Robert S
Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial. [electronic resource] - Cardiovascular diabetology 06 2019 - 77 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1475-2840
10.1186/s12933-019-0882-5 doi
Aged
Aged, 80 and over
Blood Flow Velocity
Blood Viscosity--drug effects
Cross-Over Studies
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Female
Humans
Lower Extremity--blood supply
Male
Microcirculation--drug effects
Middle Aged
New York City
Peripheral Arterial Disease--blood
Platelet Aggregation Inhibitors--adverse effects
Regional Blood Flow
Ticagrelor--adverse effects
Time Factors
Treatment Outcome
Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial. [electronic resource] - Cardiovascular diabetology 06 2019 - 77 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1475-2840
10.1186/s12933-019-0882-5 doi
Aged
Aged, 80 and over
Blood Flow Velocity
Blood Viscosity--drug effects
Cross-Over Studies
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Female
Humans
Lower Extremity--blood supply
Male
Microcirculation--drug effects
Middle Aged
New York City
Peripheral Arterial Disease--blood
Platelet Aggregation Inhibitors--adverse effects
Regional Blood Flow
Ticagrelor--adverse effects
Time Factors
Treatment Outcome